Overview

Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?

Status:
Unknown status

Trial end date:
2012-01-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to determine the feasibility of conducting a trial to examine the efficacy of an ω3FA (Omega-3 fatty acid) containing balanced lipid emulsion in the prevention of progression of PNALD in infants with Intestinal Failure/Short Bowel Syndrome (SBS) and early liver dysfunction.

Phase:

Phase 2

Details

Lead Sponsor:

The Hospital for Sick Children

Collaborator:

Fresenius Kabi

Treatments:

SMOFlipid
Soybean oil, phospholipid emulsion